来吧，腹部脂肪没别的招，就是运动

Scientists know that the type of fat you can measure with a tape isn't the most dangerous.But what is the most effective way to fight internal,visceral fat that you cannot see or feel?The answer:exercise.

科学家们知道外在的由尺子测量出来的肥胖并不是最可怕的，那对抗腹部肥胖(就是那些感觉不到看不到的内脏脂肪)最有效的方式到底是什么呢?答案就是：运动。

Researchers at UT Southwestern Medical Center analyzed two types of interventions--lifestyle modification(exercise)and pharmacological(medicine)--to learn how best to defeat fat lying deep in the belly.The study is published in Mayo Clinic Proceedings.

西南医学中心的研究人员分析了两种类型的干预措施——生活方式的改变和药物使用——来了解如何更好的减少腹部脂肪的堆积。这项研究的结果发表在Mayo Clinic Proceedings上面。

"Visceral fat can affect local organs or the entire body system.Systemically it can affect your heart and liver,as well as abdominal organs,"said senior author and cardiologist Dr.Ian J.Neeland,Assistant Professor of Internal Medicine."When studies use weight or body mass index as a metric,we don't know if the interventions are reducing fat everywhere in the body,or just near the surface."

“内脏脂肪会影响局部器官或整个身体系统。系统地说，它可以影响你的心脏和肝脏，以及腹部器官。尼兰德，内科助理教授。“当研究使用体重或身体质量指数作为衡量标准时，我们不知道这些干预措施是减少了身体各处的脂肪，还是仅仅减少了身体表面的脂肪。”

To find out,the researchers evaluated changes in visceral fat in 3,602 participants over a 6-month period measured by a CT or MRI exam.Both exercise and medicines resulted in less visceral fat,but the reductions were more significant per pound of body weight lost with exercise.

为了找到答案，研究人员对3602名参与者进行了为期6个月的CT或MRI检查，评估了他们内脏脂肪的变化。运动和药物都能减少内脏脂肪，但运动后每磅体重的减少幅度更大。

"The location and type of fat is important.If you just measure weight or BMI,you can underestimate the benefit to your health of losing weight,"said Dr.Neeland,a Dedman Family Scholar in Clinical Care."Exercise can actually melt visceral fat."

脂肪生成的部位和类型很重要，如果你只是称体重或者计算BMI，你可能会低估减重对你身体的益处。运动确实可以“溶掉”你的腹部脂肪。

Participants in exercise trials were 65 percent female,with a mean age of 54 and mean BMI at enrollment of 31.Exercise regimens were monitored,not self-reported.The majority of exercise trials were performed in the U.S.and Canada,while pharmacologic trials included the U.S.,Canada,Sweden,Japan,and four multinational cohorts.

参与运动组的志愿者65%是女性，平均年龄54岁，BMI的平均值是31.参与运动组的志愿者65%是女性，平均年龄54岁，BMI的平均值是31.运动方案由系统检测，并非志愿者自我上报，这样就减少了偏差。大多数的运动干预试验在美国和加拿大进行，而药物试验部分则安排在美国，加拿大，瑞典，日本和四个多中心试验组。

The medications used by study participants were FDA approved or in the FDA approval pipeline.

研究参与者使用的药物是FDA已批准或者正在申请获批中的。